Stay updated on Amcenestrant in ER+ Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the Amcenestrant in ER+ Breast Cancer Clinical Trial page.

Latest updates to the Amcenestrant in ER+ Breast Cancer Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedResults have been posted on 2025-11-24, and the page now lists expanded study locations including Milano, Cardiff, Vancouver, Brno, Prague, Lille, Lyon, Villejuif, and Madrid. The update also adds detailed endpoints and PK/PD data across multiple arms (DLTs, ORR, CBR, DOR, PFS, etc.).SummaryDifference7%

- Check19 days agoChange DetectedPublications are automatically filled from PubMed, and the Revision tag updated to v3.3.1 (was v3.2.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check26 days agoChange DetectedAdded 'Results Submitted' status to the study record. Removed the funding-status notice and the 'No Results Posted' message.SummaryDifference0.3%

- Check40 days agoChange DetectedNo significant additions or deletions were detected on the Study Details page; the content remains focused on the AMcenestrant trial and its design.SummaryDifference0.3%

- Check69 days agoChange DetectedUpdated version to v3.2.0 and added a government-operating-status notice; removed the prior v3.1.0 tag.SummaryDifference2%

- Check76 days agoChange DetectedPage revision updated from v3.0.2 to v3.1.0, indicating a version bump with no other substantive content changes.SummaryDifference0.0%

Stay in the know with updates to Amcenestrant in ER+ Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Amcenestrant in ER+ Breast Cancer Clinical Trial page.